Gene · 4610
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene. | Front Oncol | 2023 | 36910630 | PubTator, text mining | PubMed |
| RUNX3 Meets the Ubiquitin-Proteasome System in Cancer. | Cells | 2023 | 36899853 | PubTator, text mining | PubMed |
| Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant. | Cells | 2023 | 36899834 | PubTator, text mining | PubMed |
| 9-Butyl-Harmol Exerts Antiviral Activity against Newcastle Disease Virus through Targeting GSK-3β and HSP90β. | J Virol | 2023 | 36877059 | PubTator, text mining | PubMed |
| Bariatric Surgery: Targeting pancreatic β cells to treat type II diabetes. | Front Endocrinol (Lausanne) | 2023 | 36875493 | PubTator, text mining | PubMed |
| Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer. | Ther Adv Med Oncol | 2023 | 36872947 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
| The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme. | Int J Mol Sci | 2023 | 36835628 | PubTator, text mining | PubMed |
| Pluripotent Stem Cells of Order Carnivora: Technical Perspective. | Int J Mol Sci | 2023 | 36835318 | PubTator, text mining | PubMed |
| Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. | Int J Mol Sci | 2023 | 36835130 | PubTator, text mining | PubMed |
| Hodgkin Lymphoma Cell Lines and Tissues Express mGluR5: A Potential Link to Ophelia Syndrome and Paraneoplastic Neurological Disease. | Cells | 2023 | 36831273 | PubTator, text mining | PubMed |
| Molecular Landscape and Association With Crohn Disease of Poorly Cohesive Carcinomas of the Nonampullary Small Bowel. | Am J Clin Pathol | 2023 | 36812376 | PubTator, text mining | PubMed |
| Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention. | BioTech (Basel) | 2023 | 36810441 | PubTator, text mining | PubMed |
| Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers. | Front Oncol | 2023 | 36776320 | PubTator, text mining | PubMed |
| A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle. | Molecules | 2023 | 36770809 | PubTator, text mining | PubMed |
| CD47-Dependent Regulation of Immune Checkpoint Gene Expression and MYCN mRNA Splicing in Murine CD8 and Jurkat T Cells. | Int J Mol Sci | 2023 | 36768931 | PubTator, text mining | PubMed |
| Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance. | Cancers (Basel) | 2023 | 36765949 | PubTator, text mining | PubMed |
| Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue. | Cancers (Basel) | 2023 | 36765784 | PubTator, text mining | PubMed |
| c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy. | Cancers (Basel) | 2023 | 36765581 | PubTator, text mining | PubMed |
| O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner. | Signal Transduct Target Ther | 2023 | 36765030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4610/papers?page=16